- Comprehensive cervical cancer prevention and control in the Asia Pacific region: the 6th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN)
-
Zhao FH, Qiao YL
- KMID: 2130095
- J Gynecol Oncol.
- 2014 Jul;25(3):170-171.
- doi: 10.3802/jgo.2014.25.3.170
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Pathologic Features of Multifocal and Multicentric Breast Cancer in Chinese Women: A Retrospective Cohort Study
-
Zhou MR, Tang ZH, Li J, Fan JH, Pang Y, Yang HJ, Zheng S, Bai JQ, Lv N, Qiao YL, Qi HZ, Xu F
- KMID: 2374549
- J Breast Cancer.
- 2013 Mar;16(1):77-83.
PURPOSE: This study aims to analyze the clinical-pathological characteristics of multifocal and multicentric breast cancer (MMBC) in Chinese women. METHODS: Sixty-seven cases with MMBC were randomly collected and reviewed at seven... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse
-
Feng RM, Hu SY, Zhao FH, Zhang R, Zhang X, Wallach AI, Qiao YL
- KMID: 2413216
- J Gynecol Oncol.
- 2017 Sep;28(5):e47.
- doi: 10.3802/jgo.2017.28.e47
OBJECTIVE: We performed a pooled analysis to examine cigarette smoking and household passive smoke exposure in relation to the risk of human papillomavirus (HPV) infection and cervical intraepithelial neoplasia grade... -
- CITED
-
- Close
- SHARE
-
- Close
- Prospective comparison of hybrid capture 2 and SPFâ‚â‚€-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China
-
Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH
- KMID: 2413226
- J Gynecol Oncol.
- 2017 Sep;28(5):e66.
- doi: 10.3802/jgo.2017.28.e66
OBJECTIVE: To investigate the extent of the cross-reactivity of hybrid capture 2 (HC2) assay and evaluate the potential effect of cross-reactivity on the long-term risk for cervical cancer and precancers. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
